Attached files
file | filename |
---|---|
10-Q - 10-Q - Aptalis Pharma Inc | m70832e10vq.htm |
EX-31.2 - EX-31.2 - Aptalis Pharma Inc | m70832exv31w2.htm |
EX-32.2 - EX-32.2 - Aptalis Pharma Inc | m70832exv32w2.htm |
EX-31.1 - EX-31.1 - Aptalis Pharma Inc | m70832exv31w1.htm |
EX-32.1 - EX-32.1 - Aptalis Pharma Inc | m70832exv32w1.htm |
Exhibit 3.1
STATE OF DELAWARE
CERTIFICATE OF AMENDMENT
OF THE
CERTIFICATE OF INCORPORATION
OF
AXCAN INTERMEDIATE HOLDINGS INC.
OF THE
CERTIFICATE OF INCORPORATION
OF
AXCAN INTERMEDIATE HOLDINGS INC.
Axcan Intermediate Holdings Inc., a corporation organized and existing under and by virtue of the
General Corporation Law of the State of Delaware (the Corporation),
DOES HEREBY CERTIFY:
FIRST: That the Board of Directors of the Corporation, by unanimous written consent, adopted
resolutions to effect a change in the Corporations name so that Article 1 of the Certificate of
Incorporation of the Corporation be amended by deleting Article 1 in its entirety and replacing it
with the following:
1. | Name. The name of this corporation is Aptalis Pharma Inc. |
SECOND: That, in lieu of a meeting and vote of the stockholders, the stockholders of the
Corporation have given written consent to said amendment in accordance with the provisions of
Section 228 of the General Corporation Law of the State of Delaware.
THIRD: That the aforesaid amendment was duly adopted in accordance with the applicable provisions
of Sections 242 and 228 of the General Corporation Law of the State of Delaware.
IN WITNESS WHEREOF, the Corporation has caused this Certificate to be signed on this 4th
day of May, 2011.
/s/ Steve Gannon | ||||
Steve Gannon | ||||
Senior Vice President, Chief Financial Officer and Treasurer |